Coronavirus vaccine trumps divided government in turbocharging markets: Goldman Sachs
November 11, 2020 at 11:43 AM EST
Pfizer and German partner BioNTech announced on Monday that their COVID-19 vaccine candidate, which was developed in record time, was found to have a 90% positive efficacy rate and could start being distributed before the end of the year.
